Forte Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,250
Closed -$339K 168
2017
Q4
$339K Buy
3,250
+100
+3% +$11.3K 0.1% 129
2017
Q3
$459K Hold
3,150
0.15% 112
2017
Q2
$409K Buy
3,150
+188
+6% +$23K 0.13% 114
2017
Q1
$369K Hold
2,962
0.13% 122
2016
Q4
$342K Sell
2,962
-350
-11% -$39K 0.13% 119
2016
Q3
$346K Sell
3,312
-200
-6% -$21.6K 0.13% 116
2016
Q2
$346K Hold
3,512
0.13% 118
2016
Q1
$352K Hold
3,512
0.15% 119
2015
Q4
$421K Hold
3,512
0.17% 106
2015
Q3
$380K Hold
3,512
0.17% 109
2015
Q2
$406K Buy
3,512
+62
+2% +$7.09K 0.17% 115
2015
Q1
$414K Sell
3,450
-200
-5% -$23.9K 0.18% 115
2014
Q4
$408K Buy
3,650
+200
+6% +$21.1K 0.18% 116
2014
Q3
$327K Buy
+3,450
New +$311K 0.15% 124

Other funds holding CELG

Forte Capital's CELG Position: Q1 2018 in Review

Forte Capital sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 3,250 shares — an estimated $339K sold.

Forte Capital first reported a position in CELG in Q3 2014 and held it in 14 quarters. The position peaked at $459K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Forte Capital reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Forte Capital sold 3,250 Celgene Corp shares in Q1 2018, an estimated $339K.
  • Forte Capital first reported a position in Celgene Corp in Q3 2014 and held it in 14 quarters.
  • Forte Capital's Celgene Corp position peaked at $459K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Forte Capital's 13F filing for Q1 2018, filed 17 Apr 2018.